Edition:
India

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

392.50SEK
23 Oct 2020
Change (% chg)

-5.50kr (-1.38%)
Prev Close
398.00kr
Open
398.00kr
Day's High
400.00kr
Day's Low
386.00kr
Volume
5,295
Avg. Vol
4,283
52-wk High
412.50kr
52-wk Low
139.20kr

Latest Key Developments (Source: Significant Developments)

Probi Q3 Net Sales Rise To SEK 195 Mln
Wednesday, 21 Oct 2020 

Oct 21 (Reuters) - Probi AB ::Q3 2020: STRONG GROWTH WITH GOOD PROFITABILITY.Q3 NET SALES INCREASED BY 38% (43% ADJUSTED FOR CURRENCY CHANGES) TO SEK 195 M (142).Q3 EBITDA MARGIN WAS 32% (32%)..  Full Article

Q2 2020 Probi Raises Long-Term Financial Targets
Friday, 17 Jul 2020 

July 17 (Reuters) - Probi AB ::Q2 2020: PROBI RAISES LONG-TERM FINANCIAL TARGETS.PROBI - HAS DECIDED ON NEW FINANCIAL TARGETS AND DIVIDEND POLICY.PROBI - EFFECTS ON PROBI FROM COVID-19 HAVE, OVERALL, BEEN LIMITED IN TERMS OF BOTH REVENUE AND COSTS.PROBI - UNDERLYING DEMAND FOR PROBIOTICS HAS INCREASED IN US OVER PERIOD.PROBI - WE HAVE SEEN AN INCREASE IN DEMAND FROM CUSTOMERS WITH A SIGNIFICANT PRESENCE IN E-COMMERCE SECTOR, ESPECIALLY IN US.PROBI - WE ARE RAISING OUR AMBITIONS FOR GROWTH, BOTH ORGANICALLY AND THROUGH ACQUISITIONS.PROBI - WE WILL NOT LOSE FOCUS ON PROFITABILITY AND WILL ALSO INCREASE OUR EBITDA TARGET.  Full Article

Probi And Örebro University To Collaborate On Research Into Exploration Of Novel, Needle Free Vaccines
Thursday, 2 Jul 2020 

July 2 (Reuters) - Probi AB ::PROBI AND ÖREBRO UNIVERSITY TO COLLABORATE ON RESEARCH INTO EXPLORATION OF NOVEL, NEEDLE FREE VACCINES.ÖREBRO UNIVERSITY, IN COLLABORATION WITH PROBI AB, AND NINE OTHER SWEDISH COMPANIES HAVE BEEN GRANTED FUNDING FOR RESEARCH INTO NOVEL, NEEDLE FREE VACCINES THROUGH DELIVERY VIA MUCOUS MEMBRANES INSTEAD OF USING TRADITIONAL INJECTIONS.  Full Article

Probi Q1 Net Sales Rise To SEK 158 Mln
Friday, 24 Apr 2020 

April 24 (Reuters) - Probi AB ::Q1 2020: A SOLID START TO THE YEAR.Q1 NET SALES SEK 158 MILLION VERSUS SEK 138 MILLION YEAR AGO.Q1 EBITDA MARGIN WAS 19% (20%).  Full Article

Probi And Viva5 Announce Strategic Joint Venture
Tuesday, 24 Mar 2020 

March 24 (Reuters) - Probi AB ::PROBI AND VIVA5 ANNOUNCE STRATEGIC JOINT VENTURE TO ADDRESS GROWING MARKET SEGMENTS.ENTERS A STRATEGIC JOINT VENTURE WITH US BASED HEALTH AND WELLNESS COMPANY VIVA5 GROUP.VIVA5 GROUP AND PROBI WILL OWN 51 AND 49% SHARE RESPECTIVELY AND WILL HAVE EQUAL REPRESENTATION ON BOARD OF DIRECTORS.  Full Article

Prob Q4 Operating Profit Rises To SEK 34.5 Million
Tuesday, 11 Feb 2020 

Feb 11 (Reuters) - Probi AB ::Q4 NET SALES ROSE 2% DURING QUARTER TO MSEK 166.-Q4 PROFITABILITY IMPROVED AND EBITDA MARGIN WAS 29% FOR FULL-YEAR 2019.I STILL FEEL CONFIDENT THAT WE WILL SHOW INCREASED GROWTH IN 2020 - CEO.BOARD PROPOSES THAT 2020 ANNUAL GENERAL MEETING APPROVES A DIVIDEND OF SEK 1.00 (0.00) PER SHARE CORRESPONDING TO MSEK 11.6 (0) FOR 2019.Q4 OPERATING PROFIT SEK 34.5 MILLION VERSUS SEK 30.6 MILLION YEAR AGO.Q4 NET SALES SEK 166.1 MILLION VERSUS SEK 162.9 MILLION YEAR AGO.  Full Article

Probi: Probi FerroSorb Concept Effective In Preventing Iron Deficiency Anemia During Pregnancy
Wednesday, 19 Jun 2019 

June 19 (Reuters) - Probi AB ::NEW STUDY - THE PROBI FERROSORB® CONCEPT EFFECTIVE IN PREVENTING IRON DEFICIENCY ANEMIA DURING PREGNANCY.RESULTS PROVIDE EVIDENCE THAT IRON STATUS IS SIGNIFICANTLY IMPROVED FOR PREGNANT WOMEN AFTER INTAKE OF PROBI FERROSORB.EFFECT WAS MEASURED ON IRON STATUS AND TREATMENT WITH PROBIOTIC PRODUCT SHOWED SIGNIFICANT IMPROVEMENT COMPARED TO.TREATMENT RESULTED IN REDUCED IRON DEFICIENCY, AND ALSO SIGNIFICANTLY REDUCED PREVALENCE OF ANEMIA AND IRON DEFICIENCY ANEMIA DURING LAST TRIMESTER OF PREGNANCY IN HEALTHY, PREGNANT WOMEN.  Full Article

Probi Q1 Operating Profit Rises To SEK 11.3 Million
Monday, 29 Apr 2019 

April 29 (Reuters) - Probi AB ::Q1 2019: REVENUE GROWTH AND STRONG CASH FLOW STARTS THE YEAR.Q1 NET SALES SEK 138.2 MILLION VERSUS SEK 119.2 MILLION YEAR AGO.STRONG CUSTOMER INTEREST AND SEVERAL CUSTOMER LAUNCHES PLANNED IN 2019.Q1 OPERATING PROFIT SEK 11.3 MILLION VERSUS SEK 4.4 MILLION YEAR AGO.  Full Article

Probi Q4 Operating Profit Rises To SEK 30.6 Million
Wednesday, 13 Feb 2019 

Feb 13 (Reuters) - Probi AB ::FOURTH-QUARTER NET SALES ROSE TO MSEK 163, UP 36%, OR MSEK 43 COMPARED WITH YEAR-ON-YEAR PERIOD.BOARD OF DIRECTORS PROPOSE THAT 2019 ANNUAL GENERAL MEETING RESOLVES THAT NO DIVIDENDS WILL BE PAID FOR 2018 FINANCIAL YEAR.Q4 OPERATING PROFIT SEK 30.6 MILLION VERSUS SEK 7.6 MILLION YEAR AGO.  Full Article